Nanoscale, 2015, Accepted Manuscript
DOI: 10.1039/C5NR05552K, Minireview
DOI: 10.1039/C5NR05552K, Minireview
Hisataka Kobayashi, Peter L Choyke
To date, the delivery of nano-sized therapeutic agents to cancers largely relies on enhanced permeability and retention (EPR) effects that are caused by the leaky nature of cancer vasculature. However,...
The content of this RSS Feed (c) The Royal Society of Chemistry
To date, the delivery of nano-sized therapeutic agents to cancers largely relies on enhanced permeability and retention (EPR) effects that are caused by the leaky nature of cancer vasculature. However,...
The content of this RSS Feed (c) The Royal Society of Chemistry
Click for full article
No comments:
Post a Comment